Dan Buskila

2.6k total citations · 1 hit paper
47 papers, 1.9k citations indexed

About

Dan Buskila is a scholar working on Psychiatry and Mental health, Rheumatology and Pharmacology. According to data from OpenAlex, Dan Buskila has authored 47 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Psychiatry and Mental health, 11 papers in Rheumatology and 10 papers in Pharmacology. Recurrent topics in Dan Buskila's work include Fibromyalgia and Chronic Fatigue Syndrome Research (24 papers), Musculoskeletal pain and rehabilitation (10 papers) and Systemic Lupus Erythematosus Research (9 papers). Dan Buskila is often cited by papers focused on Fibromyalgia and Chronic Fatigue Syndrome Research (24 papers), Musculoskeletal pain and rehabilitation (10 papers) and Systemic Lupus Erythematosus Research (9 papers). Dan Buskila collaborates with scholars based in Israel, United Kingdom and United States. Dan Buskila's co-authors include Lily Neumann, Mahmoud Abu‐Shakra, Joseph Press, S Sukenik, Bente Danneskiold‐Samsøe, Fitnat Dinçer, Chris Henriksson, Eva Kosek, Alan J. Silman and Serena Carville and has published in prestigious journals such as Annals of the Rheumatic Diseases, The American Journal of Gastroenterology and Medical Care.

In The Last Decade

Dan Buskila

47 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

EULAR evidence-based recommendations for the management of fibromyalgia syndrome

2007 561 citations Serena Carville, Lars Arendt‐Nielsen et al. Annals of the Rheumatic Diseases profile →

Peers

Dan Buskila

PMH

PHARM

RHEUM

CN

CB

Alita Hidding Netherlands

Sawsan As‐Sanie United States

Tracy V. Ting United States

Terence W. Starz United States

Randy S. Roth United States

Keith M. Smart Ireland

Hilary Wilson United States

Thomas Brockow Germany

Şehim Kutlay Türkiye

John F. Steege United States

Alita Hidding Netherlands

Dan Buskila

668 ×0.6

PMH

966 ×1.2

PHARM

545 ×1.9

RHEUM

183 ×0.8

CN

189 ×1.0

CB

Citations per year, relative to Dan Buskila Dan Buskila (= 1×) peers Alita Hidding

Countries citing papers authored by Dan Buskila

Since Specialization

Citations

This map shows the geographic impact of Dan Buskila's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Buskila with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Buskila more than expected).

Fields of papers citing papers by Dan Buskila

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Buskila. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Buskila. The network helps show where Dan Buskila may publish in the future.

Co-authorship network of co-authors of Dan Buskila

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Buskila. A scholar is included among the top collaborators of Dan Buskila based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Buskila. Dan Buskila is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Ablin, Jacob N., Dan Buskila, Howard Amital, et al.. (2014). A Paradigm Change for Treatment Strategies for Fibromyalgia Syndrome Reflected by Recommendations of Recent Evidence-Based Interdisciplinary Guidelines Developed Independently in Three Countries. mediaTUM (Technical University of Munich). 3 indexed citations

2.

Ablin, Jacob N., Howard Amital, Michael Ehrenfeld, et al.. (2013). [Guidelines for the diagnosis and treatment of the fibromyalgia syndrome].. PubMed. 152(12). 742–7, 751, 750. 41 indexed citations

3.

Glazer, Yael, et al.. (2010). Are psychological distress symptoms different in fibromyalgia patients compared to relatives with and without fibromyalgia?. PubMed. 27(5 Suppl 56). S11–5. 7 indexed citations

4.

Ablin, Jacob N., Dan Buskila, & Daniel J. Clauw. (2009). Biomarkers in fibromyalgia. Current Pain and Headache Reports. 13(5). 343–349. 24 indexed citations

5.

Carville, Serena, Lars Arendt‐Nielsen, Henning Bliddal, et al.. (2007). EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Annals of the Rheumatic Diseases. 67(4). 536–541. 561 indexed citations breakdown →

6.

Amir, Marianne, et al.. (2002). Psychometric Properties of the SF-12 (Hebrew Version) in a Primary Care Population in Israel. Medical Care. 40(10). 918–928. 69 indexed citations

7.

Mader, Reuven, Lea Ziporen, Lily Neumann, & Dan Buskila. (2002). Antiphospholipid Antibodies in a Heterogeneous Group of Patients: Experience from a Central Laboratory. Clinical Rheumatology. 21(5). 386–390. 3 indexed citations

8.

Buskila, Dan & Joseph Press. (2001). Neuroendocrine mechanisms in fibromyalgia–chronic fatigue. Best Practice & Research Clinical Rheumatology. 15(5). 747–758. 32 indexed citations

9.

Sperber, Ami D., Sara Carmel, Yael Shalit, et al.. (2000). Use of the Functional Bowel Disorder Severity Index (FBDSI) in a study of patients with the irritable bowel syndrome and fibromyalgia. The American Journal of Gastroenterology. 95(4). 995–998. 73 indexed citations

10.

Buskila, Dan. (2000). Fibromyalgia, chronic fatigue syndrome, and myofascial pain syndrome. Current Opinion in Orthopedics. 11(1). 49–55. 1 indexed citations

11.

Buskila, Dan. (1999). Drug therapy. Best Practice & Research Clinical Rheumatology. 13(3). 479–485. 10 indexed citations

12.

Buskila, Dan. (1999). Fibromyalgia, chronic fatigue syndrome, and myofascial pain syndrome. Current Opinion in Rheumatology. 11(2). 119–126. 14 indexed citations

13.

Buskila, Dan, Alla Shnaider, Lily Neumann, et al.. (1998). Musculoskeletal manifestations and autoantibody profilein 90 hepatitis C virus infected israeli patients. Seminars in Arthritis and Rheumatism. 28(2). 107–113. 92 indexed citations

14.

Sikuler, Emanuel, A. Yaari, Yonat Shemer‐Avni, et al.. (1998). HCV antibodies in saliva and urine. Journal of Medical Virology. 55(1). 24–27. 1 indexed citations

15.

Reifen, Ram, Dan Buskila, Maximo Maislos, Joseph Press, & Amit Lerner. (1997). Serum prolactin in coeliac disease: a marker for disease activity. Archives of Disease in Childhood. 77(2). 155–157. 25 indexed citations

16.

Neumann, Lily & Dan Buskila. (1997). Quality of life and physical functioning of relativesof fibromyalgia patients. Seminars in Arthritis and Rheumatism. 26(6). 834–839. 47 indexed citations

17.

Sukenik, S, et al.. (1995). Balneotherapy for rheumatoid arthritis at the Dead Sea.. PubMed. 31(4). 210–4. 39 indexed citations

18.

Piura, Benjamin, et al.. (1991). Antinuclear Autoantibodies in Healthy Nonpregnant and Pregnant Women and Their Offspring. American Journal of Reproductive Immunology. 26(1). 28–31. 7 indexed citations

19.

Sukenik, S, et al.. (1987). Impotence, carpal tunnel syndrome and peripheral neuropathy as presenting symptoms in progressive systemic sclerosis.. PubMed. 14(3). 641–3. 17 indexed citations

20.

Buskila, Dan, Shmuel Argov, David Isenberg, et al.. (1987). Low serum antimycobacterial glycolipid antibody titers in the sera of patients with systemic lupus erythematosus associated with central nervous system involvement.. PubMed. 14(3). 507–11. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact